Literature DB >> 30057165

Hemodynamics and its predictors during Impella-protected PCI in high risk patients with reduced ejection fraction.

Giulio Russo1, Francesco Burzotta2, Domenico D'Amario1, Flavio Ribichini3, Anna Piccoli3, Lazzaro Paraggio1, Leonardo Previ1, Gabriele Pesarini3, Italo Porto1, Antonio Maria Leone1, Giampaolo Niccoli1, Cristina Aurigemma1, Diana Verdirosi1, Carlo Trani1, Filippo Crea1.   

Abstract

BACKGROUND: Percutaneous ventricular-assistance by Impella (IMP) represents an emerging strategy to manage patients with reduced left-ventricular (LV) ejection-fraction (EF) undergoing percutaneous-coronary-intervention (PCI). The hemodynamic behave during IMP-protected PCI has been scarcely investigated.
METHODS: We reviewed the IMP console's function and hemodynamic data (which are continuously recorded during assistance) in a consecutive series of 37 patients who underwent elective IMP-protected PCI in two high-volume centers. All patients had multivessel disease and impaired LVEF. Coronary artery disease burden was graded using the British-Cardiovascular-Intervention-Society jeopardy-score (BCIS-JS) score. IMP motor speed and pressure signals (systolic blood pressure, SBP, and mean blood pressure, MBP) were analyzed. Primary hemodynamic end-points were "critical systolic blood pressure (SBP) drop" (SBP decrease ≥ 20 mm Hg reaching ≤90 mm Hg values) and "critical mean blood pressure (MBP) drop" (MBP decrease reaching ≤60 mm Hg).
RESULTS: Over mean assistance duration of 254 ± 549 min, no IMP motor drop occurred. During PCI, SBP and MBP significantly decreased but all patients had SBP values >78 mm Hg. Critical SBP and MBP drops occurred in 10.8% of patients. Among all baseline and procedural characteristics, BCIS-JS was the only significant predictor of SBP drop (p = 0.001) while BCIS-JS and LV end-diastolic volume significantly predicted MBP drop (p = 0.001 for both).
CONCLUSIONS: In patients with reduced EF undergoing IMP-protected PCI, a significant pressure decrease occurs during PCI but pressure is systematically maintained at levels warranting vital organ perfusion. Critical pressure drops during PCI occur in some patients with higher jeopardized myocardium and left ventricular diastolic volumes.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hemodynamics; High-risk PCI; Impella; Left ventricular dysfunction

Mesh:

Year:  2018        PMID: 30057165     DOI: 10.1016/j.ijcard.2018.07.064

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Temporary mechanical circulatory support for refractory heart failure: the German Heart Center Berlin experience.

Authors:  Gaik Nersesian; Felix Hennig; Marcus Müller; Johanna Mulzer; Dmytro Tsyganenko; Christoph Starck; Tom Gromann; Volkmar Falk; Evgenij Potapov; Felix Schoenrath
Journal:  Ann Cardiothorac Surg       Date:  2019-01

2.  Long-Term Outcomes of Extent of Revascularization in Complex High Risk and Indicated Patients Undergoing Impella-Protected Percutaneous Coronary Intervention: Report from the Roma-Verona Registry.

Authors:  Francesco Burzotta; Giulio Russo; Flavio Ribichini; Anna Piccoli; Domenico D'Amario; Lazzaro Paraggio; Leonardo Previ; Gabriele Pesarini; Italo Porto; Antonio Maria Leone; Giampaolo Niccoli; Cristina Aurigemma; Diana Verdirosi; Filippo Crea; Carlo Trani
Journal:  J Interv Cardiol       Date:  2019-04-09       Impact factor: 2.279

3.  Effect of Combined Spinal-Epidural Anesthesia and Total Intravenous Anesthesia on Hemodynamics and Pregnancy Outcomes of Severe Preeclampsia Pregnant Patients Undergoing Cesarean Section.

Authors:  Guangrong Wang; Pengyu Zhang; Minghui Li; Xiujuan Wu; Hua Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-22       Impact factor: 2.629

4.  Impact of left-ventricular end-diastolic pressure as a predictor of periprocedural hemodynamic deterioration in patients undergoing Impella supported high-risk percutaneous coronary interventions.

Authors:  Fadi Al-Rashid; Amir A Mahabadi; Laura Johannsen; Julian Soldat; Iryna Dykun; Rolf Alexander Jánosi; Matthias Totzeck; Tienush Rassaf
Journal:  Int J Cardiol Heart Vasc       Date:  2019-11-26

5.  Exploring Personal Protection During High-Risk PCI in a COVID-19 Patient: Impella CP Mechanical Support During ULMCA Bifurcation Stenting.

Authors:  Luca Bettari; Gaetano Pero; Cristian Maiandi; Antonio Messina; Matteo Saccocci; Marco Cirillo; Giovanni Troise; Elena Conti; Claudio Cuccia; Diego Maffeo
Journal:  JACC Case Rep       Date:  2020-04-10

6.  Can we have a rationalized selection of intra-aortic balloon pump, Impella, and extracorporeal membrane oxygenation in the catheterization laboratory?

Authors:  Giulio Russo; Francesco Burzotta; Cristina Aurigemma; Daniela Pedicino; Enrico Romagnoli; Carlo Trani
Journal:  Cardiol J       Date:  2020-12-21       Impact factor: 2.737

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.